Chad J. Kolean

2022

In 2022, Chad J. Kolean earned a total compensation of $461.6K as Chief Financial Officer at Cellectar Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$113,146
Option Awards$58,080
Salary$290,417
Total$461,643

Kolean received $290.4K in salary, accounting for 63% of the total pay in 2022.

Kolean also received $113.1K in non-equity incentive plan and $58.1K in option awards.

Rankings

In 2022, Chad J. Kolean's compensation ranked 4,482nd out of 5,756 executives tracked by ExecPay. In other words, Kolean earned more than 22.1% of executives.

ClassificationRankingPercentile
All
4,482
out of 5,756
22nd
Division
Manufacturing
2,519
out of 3,133
20th
Major group
Chemicals And Allied Products
1,208
out of 1,419
15th
Industry group
Drugs
1,135
out of 1,320
14th
Industry
Pharmaceutical Preparations
828
out of 966
14th
Source: SEC filing on April 26, 2024.

Kolean's colleagues

We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2022.

2022

James Caruso

Cellectar Biosciences

Chief Executive Officer

2022

Jarrod Longcor

Cellectar Biosciences

Chief Operating Officer

News

You may also like